INTEGERATE: Is Integrated Geriatric Assessment and Treatment Effective in older adults with cancer receiving cytotoxic chemotherapy, targeted therapy or immunotherapy? A Randomised Controlled Study
- Conditions
- Cancer in older adultsCancer - Any cancer
- Registration Number
- ACTRN12614000399695
- Lead Sponsor
- Eastern Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 154
1. Aged 70 years or older
2. Pathologically confirmed solid organ cancer or diffuse large B-cell lymphoma
3. Planned for cytotoxic chemotherapy, targeted therapy or immunotherapy
4. Able to effectively understand the language of the quality of life questionnaires in one of the validated languages for the questionnaires
5. Able to give written informed consent before randomisation according to local, national and international regulations
1. Have received cytotoxic chemotherapy, targeted therapy or immunotherapy within 3 months prior to enrolment
2. Unable to self-complete the health-related quality of life questionnaires
3. Any condition (e.g. psychological, geographical, etc.) that does not permit compliance with the protocol
4. Prior enrolment in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method